NCT00047632View on ClinicalTrials.gov

Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer

PHASE3TerminatedINTERVENTIONAL

Enrollment

847

Participants

Timeline

Start Date

October 31, 2001

Study Completion Date

February 28, 2006

Conditions

Ovarian CarcinomaPeritoneal Carcinoma

Interventions

DRUG

Interferon gamma-1b

100 mcg, SQ, 3x per week

Trial Locations (1)

94005

InterMune, Inc., Brisbane

Sponsors

Lead Sponsor

All Listed Sponsors

lead

InterMune

INDUSTRY